Please log in to view this page
Username
Password
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
